Integral Health Asset Management’s Jasper Therapeutics JSPR Stock Holding History

Integral Health Asset Management’s Portfolio JSPR Stock Details JSPR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-590,000	Closed	-$3.27M	–	85
2025 Q2	$3.27M	Buy	590,000 +15,000	+3%	+$73.9K	0.31%	65
2025 Q1	$2.47M	Sell	575,000 -75,000	-12%	-$499K	0.27%	71
2024 Q4	$13.9M	Buy	650,000 +300,000	+86%	+$6.25M	1.23%	30
2024 Q3	$6.58M	Buy	+350,000	New	+$6.97M	0.78%	38

Other funds holding JSPR

Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return

Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return

Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return

Kingdon Capital Management New York $597M AUM 51.11% 1-Year Est. Return

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Carlyle Group Washington, District of Columbia $10.6B AUM 11.25% 1-Year Est. Return

Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Investment Management

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Propel Bio Management Los Angeles, California $159M AUM 60.94% 1-Year Est. Return